Natural Phenomenon or Process – Page 4

healthcare budget cuts, CDC layoffs, NIH funding reduction, public health impact, Trump administration, federal workforce reduction, medical research funding

Novo Nordisk Pursues $830 Million Fraud Claim Against KBP Biosciences Over Failed Hypertension Drug

4 months ago talkbio0Tagged Arbitrating, asset, Biosciences, Clinical Trials, Failure (biologic function), Fraud, Freezing, Hypertensive disease, kilobase pairs, Nordisk, Ocedurenone

Novo Nordisk, KBP Biosciences, ocedurenone, fraud, asset freeze, clinical trial failure, hypertension drug, arbitration

Massive Layoffs Sweep Federal Health Agencies: Thousands of Workers Impacted Across HHS

4 months ago talkbio0Tagged Administration occupational activities, Centers for Disease Control and Prevention (U.S.), federal, Health agencies, HHS layoffs, Myasthenic Syndromes, Congenital, NIH, NIH Mouse, probationary workers, Transplant Registry Unified Management Program, United States Food and Drug Administration

HHS layoffs, federal health agencies, probationary workers, Trump administration, workforce reduction, CDC, NIH, FDA, CMS

Inventiva Slashes Workforce and Pipeline to Focus on MASH Drug Lanifibranor

4 months ago talkbio0Tagged Inventiva, lanifibranor, MASH, Phase 3 trial, pipeline, restructuring

Inventiva, layoffs, pipeline reduction, lanifibranor, MASH, Phase 3 trial, biotech restructuring

ViiV Healthcare’s Multifaceted Approach to Combating HIV in Black Communities

4 months ago talkbio0Tagged Black Populations, care activity, Community, community grants, HIV Prevention, Indication of (contextual qualifier), Risk, Social stigmata, ViiV Healthcare

ViiV Healthcare, HIV prevention, Black communities, Risk to Reasons, community grants, stigma reduction, education, access to care

X4 Pharmaceuticals Restructures to Advance Mavorixafor for Chronic Neutropenia and Optimize XOLREMDI Promotion

4 months ago talkbio0Tagged Antagonist muscle action, Chronic neutropenia, CXCR4 gene, strategic, WHIM syndrome, Xolremdi

X4 Pharmaceuticals, mavorixafor, XOLREMDI, CXCR4 antagonist, WHIM syndrome, chronic neutropenia, workforce reduction, strategic restructuring

Trump Administration Targets Massive Cuts to Federal Health Workforce

4 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, federal, Government, health workers, healthcare agencies, Transplant Registry Unified Management Program, United States Food and Drug Administration

federal health workers, layoffs, Trump administration, HHS, FDA, healthcare agencies, workforce reduction, government downsizing